Multiple endocrine neoplasia type 1 epidemiology and demographics: Difference between revisions
No edit summary |
(→Gender) |
||
Line 16: | Line 16: | ||
==Gender== | ==Gender== | ||
* Men and women are affected equally by multiple endocrine neoplasia type 1. | |||
* Men and women are affected equally by | |||
==Race== | ==Race== |
Revision as of 20:11, 25 August 2015
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 epidemiology and demographics |
FDA on Multiple endocrine neoplasia type 1 epidemiology and demographics |
CDC on Multiple endocrine neoplasia type 1 epidemiology and demographics |
Multiple endocrine neoplasia type 1 epidemiology and demographics in the news |
Blogs on Multiple endocrine neoplasia type 1 epidemiology and demographics |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average prevalence of _____ per 100,000 persons.
- In developed countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average prevalence of _____ per 100,000 persons.
- In developed countries, the prevalence of (insert disease state here) is _____ per 100,000 persons.
Incidence
- Worldwide, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average incidence of _____ per 100,000 persons.
- In developed countries, the incidence of (insert disease state here) is _____ per 100,000 persons.
- In developing countries/ Africa, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average incidence of _____ per 100,000 persons.
Age
- Endocrine and non-endocrine manifestations of the disease in MEN1 patients most often begin in the fourth or fifth decade. The onset of the disease is rare before age 10 years.
Gender
- Men and women are affected equally by multiple endocrine neoplasia type 1.
Race
- The prevalence of (insert disease state here) does not vary by race.
- (Insert disease state here) is more prevalent in the ____race and ____ races.
Developed Countries
- In this section you should describe the impact of the disease in developed countries.
- Incidence, prevalence, and geographical distribution or areas of interest can be mentioned, as well as the impact the disease has on society.
- For an example of a developed countries section in an epidemiology and demographics page, click here.
Developing Countries
- In this section you should describe the impact of the disease in developing countries.
- Incidence, prevalence, and geographical distribution or areas of interest can be mentioned, as well as the impact the disease has on society.
- For an example of a developing countries section in an epidemiology and demographics page, click here.